Results for tag: "Prostvac"

Prostvac is a type of vaccine used to treat prostate cancer. It is a therapeutic vaccine, meaning it is used to treat an existing condition, rather than prevent it. Prostvac works by stimulating the body's immune system to recognize and attack prostate cancer cells. It is administered as an injection, usually into the arm or thigh. Prostvac is currently in clinical trials and is not yet approved for use in the United States. However, it has been approved in Europe and is being studied in other countries. The Prostvac market is a growing field, with many companies researching and developing new treatments. Companies such as Bristol-Myers Squibb, Merck, and GlaxoSmithKline are leading the way in developing new treatments for prostate cancer. Other companies, such as ImmunoCellular Therapeutics and OncoSec Medical, are also researching and developing new treatments. Show Less Read more